STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Penumbra (NYSE: PEN) has scheduled its second quarter 2025 earnings conference call for July 29, 2025, at 4:30 PM Eastern Time. The company will release its Q2 2025 financial results after market close on the same day.

Investors can access the conference call by dialing (888) 596-4144 with conference ID 6572573, or via webcast through the "Events and Presentations" section on Penumbra's website. The webcast recording will remain available for at least two weeks after the call.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

ALAMEDA, Calif., July 1, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2025 after market close on Tuesday, July 29, 2025 at 4:30 PM Eastern Time. A press release with second quarter 2025 financial results will be issued after market close that day.

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations
Penumbra, Inc.
investors@penumbrainc.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-second-quarter-2025-earnings-release-and-conference-call-for-july-29-2025-302489990.html

SOURCE Penumbra, Inc.

FAQ

When is Penumbra's (PEN) Q2 2025 earnings call scheduled?

Penumbra's Q2 2025 earnings call is scheduled for July 29, 2025 at 4:30 PM Eastern Time, following the financial results release after market close.

How can investors access Penumbra's (PEN) Q2 2025 earnings call?

Investors can access the call by dialing (888) 596-4144 (conference ID: 6572573) or via webcast on Penumbra's website under the 'Events and Presentations' section.

Where can I find the replay of Penumbra's (PEN) Q2 2025 earnings call?

The webcast replay will be available on Penumbra's website (www.penumbrainc.com) under the 'Investors' tab for at least two weeks following the call.

What time will Penumbra (PEN) release its Q2 2025 financial results?

Penumbra will release its Q2 2025 financial results after market close on Tuesday, July 29, 2025.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

11.59B
37.48M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA